| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.005 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |